CRISPR cuts gene from head and neck cancers through direct injection—50% of tumors eliminated in animal models
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...
Cancer Therapy Advisor14h
Neoadjuvant CIT and Response-Guided CRT Show Promise in Locally Advanced HNSCC
Phase 2 trial results support further development of neoadjuvant nivolumab-based CIT and adaptive de-escalation of CRT in patients with locoregionally advanced HNSCC, according to researchers.